BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10065632)

  • 41. CD1b Tetramers Identify T Cells that Recognize Natural and Synthetic Diacylated Sulfoglycolipids from Mycobacterium tuberculosis.
    James CA; Yu KKQ; Gilleron M; Prandi J; Yedulla VR; Moleda ZZ; Diamanti E; Khan M; Aggarwal VK; Reijneveld JF; Reinink P; Lenz S; Emerson RO; Scriba TJ; Souter MNT; Godfrey DI; Pellicci DG; Moody DB; Minnaard AJ; Seshadri C; Van Rhijn I
    Cell Chem Biol; 2018 Apr; 25(4):392-402.e14. PubMed ID: 29398561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family.
    Beckman EM; Melián A; Behar SM; Sieling PA; Chatterjee D; Furlong ST; Matsumoto R; Rosat JP; Modlin RL; Porcelli SA
    J Immunol; 1996 Oct; 157(7):2795-803. PubMed ID: 8816382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD1a and CD1c activate intrathyroidal T cells during Graves' disease and Hashimoto's thyroiditis.
    Roura-Mir C; Catálfamo M; Cheng TY; Marqusee E; Besra GS; Jaraquemada D; Moody DB
    J Immunol; 2005 Mar; 174(6):3773-80. PubMed ID: 15749918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation of a functional antigen-Ia complex.
    Srinivasan M; Pierce SK
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):919-22. PubMed ID: 2153978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The surprising diversity of lipid antigens for CD1-restricted T cells.
    Moody DB
    Adv Immunol; 2006; 89():87-139. PubMed ID: 16682273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens.
    Briken V; Jackman RM; Watts GF; Rogers RA; Porcelli SA
    J Exp Med; 2000 Jul; 192(2):281-8. PubMed ID: 10899914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of CD1 molecules in immune responses to infection.
    Maher JK; Kronenberg M
    Curr Opin Immunol; 1997 Aug; 9(4):456-61. PubMed ID: 9287185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Third Way: Progress on pathways of antigen processing and presentation by CD1.
    Lawton AP; Kronenberg M
    Immunol Cell Biol; 2004 Jun; 82(3):295-306. PubMed ID: 15186261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Saposin C is required for lipid presentation by human CD1b.
    Winau F; Schwierzeck V; Hurwitz R; Remmel N; Sieling PA; Modlin RL; Porcelli SA; Brinkmann V; Sugita M; Sandhoff K; Kaufmann SH; Schaible UE
    Nat Immunol; 2004 Feb; 5(2):169-74. PubMed ID: 14716313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen.
    Porcelli S; Morita CT; Brenner MB
    Nature; 1992 Dec; 360(6404):593-7. PubMed ID: 1281285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycolipid targets of CD1-mediated T-cell responses.
    Moody DB; Besra GS
    Immunology; 2001 Nov; 104(3):243-51. PubMed ID: 11722638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fatty acyl structures of mycobacterium tuberculosis sulfoglycolipid govern T cell response.
    Guiard J; Collmann A; Garcia-Alles LF; Mourey L; Brando T; Mori L; Gilleron M; Prandi J; De Libero G; Puzo G
    J Immunol; 2009 Jun; 182(11):7030-7. PubMed ID: 19454700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacterial infections promote T cell recognition of self-glycolipids.
    De Libero G; Moran AP; Gober HJ; Rossy E; Shamshiev A; Chelnokova O; Mazorra Z; Vendetti S; Sacchi A; Prendergast MM; Sansano S; Tonevitsky A; Landmann R; Mori L
    Immunity; 2005 Jun; 22(6):763-72. PubMed ID: 15963790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD1--a new paradigm for antigen presentation and T cell activation.
    Sugita M; Moody DB; Jackman RM; Grant EP; Rosat JP; Behar SM; Peters PJ; Porcelli SA; Brenner MB
    Clin Immunol Immunopathol; 1998 Apr; 87(1):8-14. PubMed ID: 9576005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunity to glycolipid antigens in microbial infections.
    De Libero G; Donda A; Mori L; Manolova V; Shamshiev A
    J Biol Regul Homeost Agents; 2001; 15(3):249-56. PubMed ID: 11693433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD1 presentation of microbial nonpeptide antigens to T cells.
    Jullien D; Stenger S; Ernst WA; Modlin RL
    J Clin Invest; 1997 May; 99(9):2071-4. PubMed ID: 9151777
    [No Abstract]   [Full Text] [Related]  

  • 57. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
    J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Participation of CD1 molecules in the presentation of bacterial protein antigens in humans.
    Ulanova M; Tarkowski A; Hahn-Zoric M; Hanson LA
    Scand J Immunol; 1999 Oct; 50(4):387-93. PubMed ID: 10520178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phage display of functional αβ single-chain T-cell receptor molecules specific for CD1b:Ac₂SGL complexes from Mycobacterium tuberculosis-infected cells.
    Camacho F; Huggett J; Kim L; Infante JF; Lepore M; Perez V; Sarmiento ME; Rook G; Acosta A
    BMC Immunol; 2013; 14 Suppl 1(Suppl 1):S2. PubMed ID: 23458512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells.
    Roark JH; Park SH; Jayawardena J; Kavita U; Shannon M; Bendelac A
    J Immunol; 1998 Apr; 160(7):3121-7. PubMed ID: 9531266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.